Companies: 10,795·Total market cap: $144.5T
China BCT Pharmacy Group, Inc.

China BCT Pharmacy Group, Inc.

CNBIOTCHealthcare
$0.00
+$0.00(+100.00%)
Market Cap$686778
P/E Ratio
52W High$0.0002
52W Low$0.0001
Overview

China BCT Pharmacy Group, Inc. (CNBI) Revenue

Annual & quarterly revenue history · segment & region breakdown

CNBI · revenue · updated Jun 10, 2026

Core revenue metrics

China BCT Pharmacy Group, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
1677 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · China BCT Pharmacy Group, Inc. SEC filings · GAAPUpdated: 2026-06-10

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
CNBI revenue by year · CNBI revenue history · CNBI annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income China BCT Pharmacy Group, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

China BCT Pharmacy Group, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from China BCT Pharmacy Group, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

CNBI revenue · 4 questions

CNBI's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

CNBI revenueCNBI annual revenuewhat is CNBI revenueCNBI TTM revenue

Source: FMP · China BCT Pharmacy Group, Inc. SEC filings · GAAP · China BCT Pharmacy Group, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026